Home Icon

Loading, Please Wait...

Pacemaker Devices Market to attain a valuation of US$8.1 Billion due to Increasing Technological Advancement - TMR

1169 Days ago

Pacemakers Device Market: Favorable Reimbursement Policy for Implantation of Pacemakers to Propel Growth

Albany, NY, April 17, 2019 (GLOBE NEWSWIRE) -- According to TMR, the global pacemaker devices market is anticipated to exhibit a healthy 8.1% CAGR from 2018 to 2022. Rising at this pace, the market is projected to attain a valuation of US$8.1 bn by 2022. Analysts noted the global pacemaker device market at US$5.5 bn in 2017.

On the basis of type, the implantable pacemakers segment led the pacemaker device market in 2017. The segment accounted for more than 65% of market share.  This is mainly because of the increase in number implantable devices and convenience of implantable pacemakers over external devices. Geographically, North America presently dominated the pacemaker devices market. This is due to the well-established healthcare infrastructure in the region. In the coming, Asia Pacific may surpass North America in terms of valuation owing to the increasing need of pacemaker devices in the region.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6586

Favorable Reimbursement Policy for Implantation of Pacemakers to Propel Growth

The global pacemaker devices market is projected to rise at a significant pace. The key factors contributing to the growth of the market are rising disposable income, growing obese population and increasing adoption of comfortable lifestyle. All these factors contribute in prevalence of the cardiovascular diseases (CVDs) directly or indirectly.  Increasing prevalence of CVDs is a major factor behind the pacemaker surgeries. This is increasing the demand of peacemaker device and thus projected to expand pacemaker devices market in the coming years.

Request PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6586

Along with this, availability of easy medical reimbursement policy for pacemakers implant is encouraging patient to opt for pacemakers. This reduces monitory burden on patients for pacemakers and its implantation. For instance, In U.S.  Average cost of a single chamber device is USD 10,000, out of this approximately 7,000 USD is reimbursed under government medical plan in U.S.  Moreover, developed countries like U.K. and Canada have similar reimbursement plan. This is anticipated to foster the growth of the global pacemaker devices market.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=6586

Technological Advancements: A Major Trend in Pacemakers Devices Market

On the flipside, increasing case of device failure and manufacturing errors in pacemakers are projected to impede growth of the global pace market device marker. Apart from this, dearth of specialized professionals to perform replacement surgeries is also expected to hamper growth in the pacemaker devices market. However factors like stringent regulations, increased investment in research and development activities in medical devices across the globe is likely to offer lucrative avenue for the growth of the global pacemaker device market.

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=6586

The global pacemaker devices market has a moderately fragmented competitive landscape. This is because of the presence of several established as well new players in the market, finds Transparency Market Research (TMR). Key manufacturers are focusing on launching of specialized products, this could further intensify completion in the pacemaker device market.  To remain competitive in such intense dynamics, companies are adopting several strategies such as business expansion, collaboration and acquisitions and mergers.

Some of the prominent players operating in the global pacemaker devices market are Biotronik SE & Co. KG, Boston Scientific Corporation,  Medtronic Plc., Lepu Medical Technology, OSYPKA AG, Pacetronix Limited, Zoll Medical Corporation, Abbott Laboratories and Oscor Inc.

Request for Ask an Analyst - https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=6586

The information is based on report is titled “Pacemaker Devices Market (Product Type - External, Implantable; End User - Hospitals, Cardiology Clinics, ASCs; Application - Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia; Technology - Single Chamber, Dual Chamber, Biventricular) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2022.”

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


Mr. Rohit Bhisey
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Research Blog:http://theglobalhealthnews.com/

We Are Diffrent
Is your business listed correctly on America’s largest city directory network of 1,000 portals? Find your City Portal